Shares of bioMerieux (OTCMKTS:BMXMF – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $125.81 and traded as low as $121.32. bioMerieux shares last traded at $121.32, with a volume of 2 shares trading hands.
bioMerieux Stock Down 3.0%
The business’s 50 day moving average is $125.81 and its two-hundred day moving average is $133.22. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08.
About bioMerieux
bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.
Featured Articles
- Five stocks we like better than bioMerieux
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Trump’s Hand-Written Letter Will Shock his Haters
- Bitcoin is down but your income is about to explode
- A month before the crash
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
